Temazepam and Actigall drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temazepam (temazepam) and Actigall (ursodiol). Common drug interactions include febrile neutropenia among females and bile duct stone among males.

The phase IV clinical study analyzes what interactions people have when they take Temazepam and Actigall. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,106 Temazepam users. Check the latest studies of Temazepam.

What is Actigall?

Actigall has active ingredients of ursodiol. It is often used in gallstones. eHealthMe is studying from 2,162 Actigall users. Check the latest studies of Actigall.



On Aug, 10, 2026

16 people who take Temazepam and Actigall together, and have interactions are studied.

Temazepam and Actigall drug interactions.

What are the common drug interactions of Temazepam and Actigall, by gender? *:

female:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Multi-organ failure (multisystem organ failure)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Cardiac failure congestive
  5. Death
  6. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  7. Urinary tract infection
  8. Abdominal pain
  9. Asthenia (weakness)
  10. Cellulitis (infection under the skin)

male:

  1. Bile duct stone
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Nausea (feeling of having an urge to vomit)
  4. Agitation (state of anxiety or nervous excitement)
  5. Anxiety
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Asthenia (weakness)
  9. Back pain
  10. Blood glucose increased

What are the common drug interactions of Temazepam and Actigall, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac failure congestive
  2. Death
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Multi-organ failure (multisystem organ failure)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Chronic kidney disease
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Pericardial effusion (fluid around the heart)
  10. Pneumonia fungal

40-49:

  1. Bile duct stone
  2. Hepatic artery thrombosis (formation of a blood clot inside a hepatic artery)
  3. Hepatitis c
  4. Hyperglycaemia (high blood sugar)
  5. Liver transplant rejection (failure of liver transplant)
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Cholangitis (infection of the bile duct)
  8. Haematoma (collection of blood outside the blood vessels)
  9. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  10. Hepatic function abnormal

50-59:

  1. Abdominal pain
  2. Agitation (state of anxiety or nervous excitement)
  3. Anxiety
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Asthenia (weakness)
  7. Back pain
  8. Blood glucose increased
  9. Coagulopathy (blood's ability to clot is impaired)
  10. Confusional state

60+:

  1. Abdominal pain
  2. Urinary tract infection
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Pneumonia
  5. Rash erythematous (redness of the skin)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Cellulitis (infection under the skin)
  8. Colitis (inflammation of colon)
  9. Diarrhoea
  10. Febrile neutropenia (fever with reduced white blood cells)

What are the existing conditions these people have? *

  1. Pain: 4 people, 25.00%
  2. White Blood Cell Count Abnormal: 2 people, 12.50%
  3. Nausea (feeling of having an urge to vomit): 2 people, 12.50%
  4. Depression: 2 people, 12.50%
  5. Diabetes: 2 people, 12.50%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
  7. Stress And Anxiety: 2 people, 12.50%
  8. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 12.50%
  9. Osteoporosis (bones weak and more likely to break): 2 people, 12.50%
  10. Pneumonia: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Temazepam and Actigall?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temazepam and Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actigall and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and ursodiol (the active ingredients of Temazepam and Actigall, respectively), and Temazepam and Actigall (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: